We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer

News   Dec 01, 2016 | NYU Langone Medical Center / New York University School of Medicine

 
Single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer
 
 
Advertisement
 

RELATED ARTICLES

The Gut Bacteria Microbiome Changes After Spinal Cord Injury

News

For the first time, researchers have used metagenomics sequencing to identify changes in gut bacteria and viruses that occur after spinal cord injuries (SCI) in mice.

READ MORE

Severe COVID-19 Alters Gray Matter Volume in the Brain

News

Covid-19 patients who receive oxygen therapy or experience fever show reduced gray matter volume in the frontal-temporal network of the brain, according to a new study.

READ MORE

Cholesterol Control Could Reduce Chronic Pain After Chemotherapy

News

Researchers have used a mouse model to demonstrate the pivotal role of cholesterol in chemotherapy-induced peripheral neuropathy and proposed a novel therapeutic approach to reverse it.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE